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Background
Previous studies indicate a role of P2X7 receptors in pro-
cesses that lead to neuronal death. The main objective of
our study was to examine whether genetic deletion or
pharmacological blockade of P2X7 receptors influenced
dopaminergic cell death in various models of Parkinson’s
disease (PD).
Methods
PC12 cells and primary mesencephalic neurons were used
in culture, and the striatum and the substantia nigra were
prepared from wild-type and P2X7 receptor knockout
mice. Rotenone and 1-methyl-4-phenyl-1,2,3,6-tetrahydro-
pyridine (MPTP) treatments were applied in vitro and
in vivo to reproduce neurochemical hallmarks of PD.
Receptor expression, cell survival indicators, and endogen-
ous biogenic amine, amino acid, adenine nucleotide and
endocannabinoid contents were analyzed.
Results
mRNA encoding P2X7 and P2X4 receptors was up-regu-
lated after treatment of PC12 cells with MPTP. P2X7
antagonists protected against MPTP- and rotenone-
induced toxicity in the LDH assay, but failed to protect
after rotenone treatment in the MTT assay in PC12
cells and in primary midbrain culture. In vivo MPTP
and in vitro rotenone pretreatments increased the
mRNA expression of P2X7 receptors in the striatum and
substantia nigra of wild-type mice. Basal mRNA expres-
sion of P2X4 receptors was higher in P2X7 knockout
mice and was further up-regulated by MPTP treatment.
Genetic deletion or pharmacological inhibition of P2X7
receptors did not change survival rate or depletion of
striatal endogenous dopamine (DA) content after in vivo
MPTP or in vitro rotenone treatment. However, deple-
tion of norepinephrine was significant after MPTP treat-
ment only in P2X7 knockout mice. The basal ATP
content was higher in the substantia nigra of wild-type
mice, but the ADP level was lower. Rotenone treatment
elicited a similar reduction in ATP content in the sub-
stantia nigra of both genotypes, whereas reduction of
ATP was more pronounced after rotenone treatment in
striatal slices of P2X7-deficient mice. Although the
endogenous amino acid content remained unchanged,
the level of the endocannabinoid, 2-arachidonoyl gly-
cerol (2-AG), was elevated by rotenone in the striatum
of wild-type mice, an effect that was absent in mice defi-
cient in P2X7 receptors.
Conclusions
We conclude that P2X7 receptor deficiency or inhibition
does not support the survival of dopaminergic neurons
in in vivo or in vitro models of PD.
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